{"bill":{"bill_id":1142032,"change_hash":"a41274397696364b8d1fa10c7bc21035","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HB321\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/321\/all-info","completed":0,"status":1,"status_date":"2019-01-08","progress":[{"date":"2019-01-08","event":1},{"date":"2019-01-08","event":9},{"date":"2019-01-25","event":9}],"state":"US","state_id":52,"bill_number":"HB321","bill_type":"B","bill_type_id":"1","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"Neuromyelitis Optica Consortium Act","description":"Requires the National Institutes of Health to establish, administer, and coordinate a national consortium on neuromyelitis optica (NMO), which is a neurological disease that can cause blindness and paralysis. The consortium must award grants for research on the causes of, and the risk factors and biomarkers associated with, NMO; assemble a panel of experts to provide guidance and recommendations on research design and protocols; and designate a central laboratory to collect and analyze data from this research and to make the data and analysis available to researchers.","pending_committee_id":2355,"committee":{"committee_id":2355,"chamber":"H","chamber_id":114,"name":"Subcommittee on Health"},"referrals":[{"date":"2019-01-08","committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"},{"date":"2019-01-25","committee_id":2355,"chamber":"H","chamber_id":114,"name":"Subcommittee on Health"}],"history":[{"date":"2019-01-08","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2019-01-08","action":"Referred to the House Committee on Energy and Commerce.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-01-25","action":"Referred to the Subcommittee on Health.","chamber":"H","chamber_id":114,"importance":1}],"sponsors":[{"people_id":9078,"person_hash":"7ingxztp","party_id":"1","state_id":52,"party":"D","role_id":1,"role":"Rep","name":"Barbara Lee","first_name":"Barbara","middle_name":"","last_name":"Lee","suffix":"","nickname":"","district":"HD-CA-13","ftm_eid":1263932,"votesmart_id":8315,"opensecrets_id":"N00008046","knowwho_pid":158726,"ballotpedia":"Barbara_Lee_(California)","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13156,"subject_name":"Department of Health and Human Services"},{"subject_id":13184,"subject_name":"Executive agency funding and structure"},{"subject_id":13212,"subject_name":"Health programs administration and funding"},{"subject_id":13608,"subject_name":"Hearing, speech, and vision care"},{"subject_id":13241,"subject_name":"Medical research"},{"subject_id":13252,"subject_name":"National Institutes of Health (NIH)"},{"subject_id":13436,"subject_name":"Neurological disorders"},{"subject_id":13267,"subject_name":"Research administration and funding"}],"texts":[{"doc_id":1868822,"date":"2019-01-23","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HB321\/id\/1868822","state_link":"https:\/\/www.congress.gov\/116\/bills\/hr321\/BILLS-116hr321ih.pdf","text_size":131913,"text_hash":"5f3da34afb8af922a4a7061c8e17a8b1"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}